FDAnews
www.fdanews.com/articles/180742-hmd-biomedical-faulted-for-design-validation

HMD Biomedical Faulted for Design Validation

March 3, 2017

Taiwan-based HMD Biomedical received a warning letter for inadequate procedures for device design validation, process control, and control of environmental conditions.

An inspection of the company’s facility in March 2016 revealed a failure to establish and maintain procedures for validating device design. In one instance, a software validation test report contained six columns for evaluation of six meters, but only two meters were marked with “OK” test results.

View today's stories